No Data
No Data
No Data
No Data
No Data
RBC Capital Reviews Bausch + Lomb's Q1 Results
Despite Bausch + Lomb reporting Q1/24 results that were ahead of consensus estimates (~3%/~2% ahead on revenue/adj. EBITDA, respectively) and reiterated 2024 guidance (higher organic growth offset by
MT NewswiresMay 2 12:29 ET
Toronto Stocks Modestly Higher as Loblaw Shares Gain on 1Q Profit Beat
Toronto stocks were modestly higher on Wednesday. Sector performance was mixed in the session, with the biggest losses logged in the process industry and energy sectors. On the gainers' side, tech, utilities and health tech outperformed.
WSJMay 1 16:31 ET · Markets
Needham Says Bausch + Lomb's Q1 Showed a "Strong Start" to The Year
Bausch + Lomb's Q1 2024 revenue and adjusted EBITDA beat consensus and management reiterated its reported financial guidance despite tougher currency. Miebo saw significant sequential growth and will
MT NewswiresMay 1 14:30 ET
Bausch & Lomb Corp (BLCO) Q1 2024 Earnings: Surpasses Revenue Estimates Amidst Net Loss Widening
Yahoo FinanceMay 1 08:33 ET
Bausch + Lomb Announces First-Quarter 2024 Results
Stockhouse May 1 06:58 ET
RBC Previews Bausch Health's Q1, Trims Target to US$11
Bausch Health will report Q1/24 results on May 2, one day after Bausch + Lomb's Q1 results. RBC estimates Q1/24 revenue of $2.13 billion (FactSet cons. $2.15 billion) and adj. EBITDA of $682 million (
MT NewswiresApr 23 11:18 ET